Cadermine cream 50ml tube #1

Name - Kadermine Cream 50ml Tube #1 Indications: Kandiderm is intended for the treatment of infectious and allergic skin diseases accompanied by secondary bacterial or fungal infection. Contraindications: Hypersensitivity to active substances or other ingredients. Tuberculosis; skin manifestations; syphilis; skin reactions after vaccination; generalized plaque psoriasis; varicose veins; dermatitis; rosacea; chickenpox, herpes; measles; bacterial and fungal skin infections without appropriate antibacterial and antifungal therapy. Dosage and Administration: Kandiderm is used in adults 2-3 times a day. Before use, it is necessary to wash and dry the affected area. Then, carefully apply a thin layer of cream to the affected area. It is necessary to remove hair from the affected area to establish direct contact with the affected area. As a rule, symptoms of the disease disappear within 2-4 weeks of starting treatment, however, it is advisable to continue treatment for a few more days to prevent the recurrence of disease symptoms. Side Effects: Burning sensation, irritation, dryness, peeling, folliculitis, hypertrichosis, acneiform eruptions, skin hyperemia (erythema), pustules, epidermal peeling, stinging, swelling, itching, urticaria, pigmentation disorders, hypochromia, dermatitis, allergic contact dermatitis, skin maceration, telangiectasia, skin atrophy, stretch marks. Overdose: Signs and symptoms. Overdose of Kandiderm is unlikely, however, applying the cream to a large area may cause systemic absorption of beclometasone and gentamicin. Prolonged and excessive use of the preparation may cause suppression of pituitary-adrenal function and manifest as Cushing's symptoms. Treatment. In such cases, appropriate symptomatic therapy is prescribed. Symptoms of acute hypercorticism are reversible. If necessary, electrolyte balance correction is performed. If similar symptoms appear due to overdose, it is recommended to discontinue the use of the preparation and prescribe appropriate therapy. Use of the preparation during pregnancy and lactation. During breastfeeding, the use of the preparation is acceptable only when the result obtained from this treatment exceeds the potential harm to the child. Treatment with this preparation in high doses and for a long duration is not recommended for patients in this group. It has not been established whether corticosteroids, when used topically, can pass into breast milk as a result of systemic absorption, therefore, the necessity of using this preparation should be based on the necessity of prescribing this preparation to the mother.